| ²é¿´: 330 | »Ø¸´: 1 | ||
| ±¾Ìû²úÉú 1 ¸ö ·ÒëEPI £¬µã»÷ÕâÀï½øÐв鿴 | ||
cainiaoduiгæ (СÓÐÃûÆø)
|
[ÇóÖú]
ÇóÖú·Òë
|
|
| As a result, vessel structure and function become more normal: vessels are more mature with enhanced PVC coverage, blood flow is more homogeneous, vessel permeability and hypoxia are reduced, and importantly the delivery of systemically administered anticancer therapies into tumors is more uniform. This concept explains why antiangiogenic therapy¡¯s benefit has often been observed when it is given with chemotherapy |
» ²ÂÄãϲ»¶
Ò»Ö¾Ô¸±±½»´ó²ÄÁϹ¤³Ì×Ü·Ö358Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
¿¼ÑÐÉúÎïѧ¿¼AÇø211£¬³õÊÔ322£¬¿ÆÄ¿Éú»¯ºÍÉúÎï×ۺϣ¬Çóµ÷¼Á
ÒѾÓÐ5È˻ظ´
284Çóµ÷¼Á
ÒѾÓÐ12È˻ظ´
329Çóµ÷¼Á
ÒѾÓÐ19È˻ظ´
²ÄÁÏר˶(0856) 339·ÖÇóµ÷¼Á
ÒѾÓÐ9È˻ظ´
¹¤¿Æ277·ÖÇóµ÷¼Á²ÄÁÏ
ÒѾÓÐ9È˻ظ´
085602µ÷¼Á ³õÊÔ×Ü·Ö335
ÒѾÓÐ6È˻ظ´
µ÷¼Á
ÒѾÓÐ3È˻ظ´
315Çóµ÷¼Á
ÒѾÓÐ11È˻ظ´
298·Ö 070300Çóµ÷¼Á
ÒѾÓÐ15È˻ظ´
reko34
ľ³æ (ÕýʽдÊÖ)
- ·ÒëEPI: 132
- Ó¦Öú: 117 (¸ßÖÐÉú)
- ½ð±Ò: 4794.2
- É¢½ð: 22
- ºì»¨: 12
- Ìû×Ó: 780
- ÔÚÏß: 417.4Сʱ
- ³æºÅ: 3055206
- ×¢²á: 2014-03-15
- ÐÔ±ð: GG
- רҵ: »úе²âÊÔÀíÂÛÓë¼¼Êõ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¡ï ¡ï ¡ï ¡ï ¡ï ¡ï
RXMCDM: ½ð±Ò+1 2014-05-07 12:29:37
cainiaodui: ½ð±Ò+5, ·ÒëEPI+1 2014-05-07 13:32:37
RXMCDM: ½ð±Ò+1 2014-05-07 12:29:37
cainiaodui: ½ð±Ò+5, ·ÒëEPI+1 2014-05-07 13:32:37
| µÃµ½µÄÒ»¸ö½á¹ûÊÇ£¬Ñª¹Ü½á¹¹ºÍ¹¦ÄܱäµÃ¸ü¼ÓÕý³££ºÔöÇ¿µÄPVC¸²¸ÇʹѪ¹Ü¸ü³ÉÊ죬ѪÁ÷¸ü¾ùÔÈ£¬Ñª¹ÜÉøÍ¸ÐÔºÍȱÑõ¼õÉÙ£¬ÖØÒªµÄÊÇÈ«ÉíÐÔÊ©ÓõĿ¹°©ÁÆ·¨¸ü¾ùÔȵؽøÈëÖ×Áö¡£ÕâÖÖ¹Ûµã½âÊÍÁËΪʲô»¯ÁÆÖо³£¹Û²ìµ½¿¹°©ÁÆ·¨µÄÒæ´¦¡£ |
2Â¥2014-05-07 11:39:29














»Ø¸´´ËÂ¥